Cargando…
Early onset muscle weakness and disruption of muscle proteins in mouse models of spinal muscular atrophy
BACKGROUND: The childhood neuromuscular disease spinal muscular atrophy (SMA) is caused by mutations or deletions of the survival motor neuron (SMN1) gene. Although SMA has traditionally been considered a motor neuron disease, the muscle-specific requirement for SMN has never been fully defined. The...
Autores principales: | Boyer, Justin G, Murray, Lyndsay M, Scott, Kyle, De Repentigny, Yves, Renaud, Jean-Marc, Kothary, Rashmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852932/ https://www.ncbi.nlm.nih.gov/pubmed/24119341 http://dx.doi.org/10.1186/2044-5040-3-24 |
Ejemplares similares
-
Differential induction of muscle atrophy pathways in two mouse models of spinal muscular atrophy
por: Deguise, Marc-Olivier, et al.
Publicado: (2016) -
Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy
por: Boyer, Justin G., et al.
Publicado: (2014) -
Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy
por: Bowerman, Melissa, et al.
Publicado: (2012) -
Defects in pancreatic development and glucose metabolism in SMN-depleted mice independent of canonical spinal muscular atrophy neuromuscular pathology
por: Bowerman, Melissa, et al.
Publicado: (2014) -
Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice
por: Deguise, Marc-Olivier, et al.
Publicado: (2017)